Amount raised
$2.5M
Round
Series B
Date raised
October 4, 2026
Founded
2020
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About Celaid Therapeutics
a biotechnology startup originating from the University of Tokyo and the University of Tsukuba, with proprietary technology for the selective ex vivo expansion of hematopoietic stem cells (HSCs)
- How much did Celaid Therapeutics raise?
- Celaid Therapeutics raised $2.5M in a Series B round on October 4, 2026.
- Who founded Celaid Therapeutics?
- No founder is listed for Celaid Therapeutics yet.
- Where is Celaid Therapeutics based?
- Celaid Therapeutics is based in Bunkyo-ku, Japan.